Sylvia L. Asa
← Back to Case Western Reserve University
Case Western Reserve University
Sylvia L. Asa works in Neuroendocrine Tumor Research Advances, Pituitary Gland Disorders and Treatments, Thyroid Cancer Diagnosis and Treatment, Adrenal and Paraganglionic Tumors, Thyroid and Parathyroid Surgery. Recorded institutional associations include University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The Immune Landscape of Cancer
2018 · 5,739 citationsAn Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
2018 · 3,681 citationsThe repertoire of mutational signatures in human cancer
2020 · 3,468 citationsOncogenic Signaling Pathways in The Cancer Genome Atlas
2018 · 3,175 citationsIntegrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3,062 citationsPan-cancer analysis of whole genomes
2020 · 3,054 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
2018 · 2,521 citationsRevised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 · 2,444 citationsComprehensive Characterization of Cancer Driver Genes and Mutations
2018 · 2,298 citationsMachine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
2018 · 2,172 citationsNomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
2016 · 1,404 citationsThe prevalence of pituitary adenomas
2004 · 1,345 citationsThe American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016 · 1,343 citationsA common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
2018 · 1,163 citationsOverview of the 2022 WHO Classification of Thyroid Neoplasms
2022 · 1,158 citationsGenomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
2018 · 1,136 citationsGenomic and Functional Approaches to Understanding Cancer Aneuploidy
2018 · 1,062 citationsThe evolutionary history of 2,658 cancers
2020 · 1,046 citationsOverview of the 2022 WHO Classification of Neuroendocrine Neoplasms
2022 · 1,036 citationsSpatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
2018 · 1,022 citationsAmerican Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012 · 935 citationsComprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
2018 · 897 citationsPathogenetic mechanisms in thyroid follicular-cell neoplasia
2006 · 893 citationsInduction of intestinal epithelial proliferation by glucagon-like peptide 2.
1996 · 880 citationsPatterns of somatic structural variation in human cancer genomes
2020 · 866 citations
